Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00849394 · ClinicalTrials.gov registry record
Evaluation of Protein in the Urine in Patients Receiving Bevacizumab
A clinical trial, sponsored by North Texas Veterans Healthcare System.
- Completed
- Registry status
- 106
- Enrollment target
NCT00849394 is a clinical trial that has completed, run by North Texas Veterans Healthcare System. The registered enrollment target is 106 participants.
The verdict
NCT00849394 has completed, sponsored by North Texas Veterans Healthcare System.
- COMPLETED
- Registry status
- 106 participants
- Enrollment target
Study Summary
This is a clinical research study to look at the incidence of proteinuria (a condition in which urine contains an abnormal amount of protein) caused by shortened infusions (given into the vein over 10 or 15 minutes) of bevacizumab (a medication prescribed for colon, lung, or breast cancer). There are currently no published studies or clinical data looking at how safe shortened infusions of bevacizumab are in relationship to the side effect of proteinuria. We hypothesis that shortened infusions of bevacizumab will result in an increased risk for proteinuria compared to the standard infusions of this agent.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2007-11 |
| Est. Completion | 2012-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00849394
The ClinicalTrials.gov registry entry for NCT00849394 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is North Texas Veterans Healthcare System, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00849394 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00849394 about?
NCT00849394 is a clinical study titled "Evaluation of Protein in the Urine in Patients Receiving Bevacizumab". This is a clinical research study to look at the incidence of proteinuria (a condition in which urine contains an abnormal amount of protein) caused by shortened infusions (given into the vein over 10 or 15 minutes) of bevacizumab (a medication prescribed for colon, lung, or breast cancer). There ar...
What is the current status of trial NCT00849394?
This trial is currently completed. The enrollment target is 106 participants. The study started on 2007-11. Estimated completion is 2012-06.
Who is sponsoring clinical trial NCT00849394?
This trial is sponsored by North Texas Veterans Healthcare System, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.